The FDA has updated the labeling for Kisunla™ (donanemab-azbt) to include a new recommended titration dosing schedule for adults with early symptomatic Alzheimer disease.

Music therapy plus standard analgesia vs standard care alone reduced pain and anxiety in patients with nontrauma-related pain in the emergency department.